cellular immunodeficiency

cellular immunodeficiency

n.
Any of a group of disorders associated with recurrent bacterial, fungal, protozoal, and viral infections and characterized by atrophy of the thymus gland, depressed cell-mediated immunity, and defective humoral immunity. Also called Nezelof type of thymic alymphoplasia.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
References in periodicals archive ?
T-cell subpopulation and T-cell stimulation tests did not show signs of cellular immunodeficiency. Antibiotic regimen was changed to flucloxacillin.
To the Editor: Mycobacterium shigaense is a novel, slow-growing, scotochromogenic mycobacterium (1), initially reported in 2012 as an opportunistic pathogen isolated from skin biopsy samples from a patient with a history of Hodgkin disease and severe cellular immunodeficiency. We describe the identification of this species in a chronic cutaneous infection in an immunocompetent woman.
nov., a novel slowly growing scotochromogenic mycobacterium that produced nodules in an erythroderma patient with severe cellular immunodeficiency and a history of Hodgkin's disease.
This raised the suspicion of cellular immunodeficiency. Anti-HIV test was found negative.
Pneumocystic Carini pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency N.
It appears almost exclusively among people with cellular immunodeficiency, and it can occur with revaccination of people who have become immunosuppressed since their primary vaccination.
It appears almost exclusively among people with cellular immunodeficiency and it can occur with revaccination of people who have become immunosuppressed since their primary vaccination.
Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305:1425-31.
Although severe cellular immunodeficiency can often facilitate the development of many infections, only 4 clinical cases of TB in patients undergoing HCV antiviral therapy have been described in the literature (6-8), and only 1 of these was clearly described as a TB reactivation (7).
Pecher and Funchs suggested that patients with lacaziosis have a cellular immunodeficiency (5).
However, since Jorge Lobo disease is restricted to specific areas of the world and the number of AIDS cases is increasing, especially in Latin America, a possible correlation between HIV infection and Jorge Lobo disease should be considered because of the associated cellular immunodeficiency.

Full browser ?